Johnson & Johnson (JNJ) Form 3 JOHNSON & JOHNSON / William Hait ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Hait William

(Last) (First) (Middle)

ONE JOHNSON & JOHNSON PLAZA

(Street)

NEW BRUNSWICK NJ 08933

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/03/2022

3. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
See Remarks

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	223,158	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options (Right to Buy)(1)	02/11/2017	02/09/2024	Common Stock	59,397	90.44	D
Employee Stock Options (Right to Buy)(1)	02/10/2018	02/09/2025	Common Stock	51,484	100.06	D
Employee Stock Options (Right to Buy)(1)	02/09/2019	02/08/2026	Common Stock	54,923	101.87	D
Employee Stock Options (Right to Buy)(1)	02/13/2020	02/13/2027	Common Stock	41,097	115.67	D
Employee Stock Options (Right to Buy)(1)	02/12/2021	02/11/2028	Common Stock	37,289	129.51	D
Employee Stock Options (Right to Buy)(1)	02/11/2022	02/11/2029	Common Stock	37,911	131.94	D
Employee Stock Options (Right to Buy)(1)	02/10/2023	02/10/2030	Common Stock	49,315	151.41	D
Employee Stock Options (Right to Buy)(1)	02/08/2024	02/08/2031	Common Stock	33,593	164.62	D
Restricted Share Units(2)	02/08/2024	(2)	Common Stock	3,059	(2)	D
Restricted Share Units(2)	02/10/2023	(2)	Common Stock	3,856	(2)	D
Restricted Share Units(2)	02/11/2022	(2)	Common Stock	7,790	(2)	D

Explanation of Responses:

1. Vested and exercisable on the third anniversary of the date of the grant.

2. Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock and vests on the third anniversary of the date of grant.

Remarks:

haitpoa1.txt Title: Executive Vice President, Chief External Innovation, Medical Safety and Global Public Health Officer

	Raavi Deol, as attorney-in-fact for William Hait	01/13/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.